Liver stiffness measurement is a potent predictor of histological fibrosis regression after hepatitis C virus clearance
Authors:
Open Access
- 6 July 2020
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 33 (4) , 547-554
Abstract
Background: Most of the studies on fibrosis regression prediction were based on noninvasive fibrosis markers and differ greatly. The ‘Beijing fibrosis classification’ can use histological results to classify fibrosis into progressive or ‘nonprogressive’ according to fibrotic septal morphology. We use this standard which served as the gold standard in order to find fibrosis regression predictors. Aim: To study the predictors of fibrosis regression after hepatitis C virus clearance according to histological fibrosis staging by the ‘Beijing fibrosis classification’. Materials and methods: This was a prospective cohort study. A total of 68 patients with advanced liver fibrosis or compensated cirrhosis who achieved sustained virological response were enrolled. Patients with the Ishak scores lower than 3 seemed to have fibrosis regression. The others were divided into the fibrosis progressive group and the nonprogressive group according to the ‘Beijing fibrosis classification’. Predictors of fibrosis regression were studied by logistic regression using baseline factors and the dynamic change in noninvasive fibrosis factors. Results: Eighteen patients were assigned to the progressive group, and the others were assigned to the nonprogressive group. The baseline liver stiffness measurements (LSMs) of the progressive and nonprogressive groups were 14.35 (11.3, 27.3) kPa and 11.3 (8.3, 14.2) kPa, respectively, P = 0.02. The baseline LSM was the only predictor of fibrosis progression. With a cutoff of 11.85 kPa, the AUC was 0.71 (0.5, 0.9), and the negative predictive value was 0.92. Conclusions: The baseline LSM was found to be the only predictor of fibrosis regression, 11.85 kPa is a possible ‘hepatic fibrosis return point’.Keywords
This publication has 19 references indexed in Scilit:
- Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling studyThe Lancet Gastroenterology & Hepatology, 2017
- New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatmentHepatology, 2016
- Reversion of disease manifestations after HCV eradicationJournal of Hepatology, 2016
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosisJournal of Hepatology, 2015
- Progressive fibrosis significantly correlates with hepatocellular carcinoma in patients with a sustained virological responseHepatology Research, 2014
- Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis CJournal of Hepatology, 2013
- A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosisHepatology, 2012
- Non-invasive evaluation of liver fibrosis using transient elastographyJournal of Hepatology, 2008
- Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis CGastroenterology, 2002
- Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patientsHepatology, 1995